Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Melphalan for Advanced Retinoblastoma
NCT01393769Phase 2Terminated
- Sponsor
- Sant Joan de Déu Hospital
- Start
- Nov 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in retinoblastoma (Rb), sponsored by Sant Joan de Déu Hospital. Started Nov 2009; status: terminated.
02
Drugs
melphalan
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT01393769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393769.